ABBOTT LABORATORIES R&D Expense 2012-2025 | ABT
Beta
What is r&d expense?
Research and development expense represents the costs incurred in discovering and developing new products, processes, or technologies.
What is ABBOTT LABORATORIES's current r&d expense?
ABBOTT LABORATORIES (ABT) annual r&d expense for 2024 was $2.84B, a 3.76% increase from 2023. ABBOTT LABORATORIES r&d expense for the quarter ending September 30, 2025 was $766.0M.
What was ABBOTT LABORATORIES's r&d expense in 2023?
ABBOTT LABORATORIES annual r&d expense for 2023 was $2.74B, a 5.09% decline from 2022.
What was ABBOTT LABORATORIES's r&d expense in 2022?
ABBOTT LABORATORIES annual r&d expense for 2022 was $2.89B, a 5.32% increase from 2021.
What is ABBOTT LABORATORIES's 5-year r&d expense CAGR?
ABBOTT LABORATORIES r&d expense grew at a compound annual growth rate (CAGR) of 3.11% from FY2019 to FY2024, going from $2.44B to $2.84B over 5 years.
R&D Expense History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR+3.1%
FY2019
$2.44B
→
FY2024
$2.84B
1718192021222324
5 years selected
Company: ABBOTT LABORATORIESTicker: ABTSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →